
RELiZORB® (iMMOBILIZED LIPASE) CARTRIDGE
RELiZORB is a digestive enzyme cartridge that contains iLipase ®, which is the enzyme lipase attached to small white beads. RELiZORB connects directly to your feeding tube, and as the …
USING RELiZORB® (iMMOBILIZED LIPASE) CARTRIDGE
Learn about setups for RELiZORB. RELiZORB is designed to connect in-line to a variety of tube-feeding setups to help meet your needs. RELiZORB setup procedures depend on feeding type …
Frequently asked questions - RELiZORB
What does RELiZORB do? Properly breaking down (digesting) and absorbing fats is important for normal growth and development. RELiZORB contains a digestive enzyme called lipase that …
GET TO KNOW THE RELiZORB® (iMMOBILIZED LIPASE) …
RELiZORB is indicated for use in pediatric patients (ages 1 year and above) and adult patients to hydrolyze fats in enteral formula. Warnings. RELiZORB is for use with enteral feeding only. …
Clinical Studies | Alcresta Therapeutics
RELiZORB is indicated for use in pediatric (ages 1 year and above) and adult patients to hydrolyze fats in enteral formula. RELiZORB is for use with enteral feeding only; do not …
Alcresta Therapeutics Announces FDA Expanded Use Clearance for RELiZORB …
Jan 16, 2025 · RELiZORB is a first-of-its-kind digestive enzyme cartridge designed to mimic the function of pancreatic lipase. RELiZORB is developed using Alcresta’s proprietary enzyme …
RELiZORB Prescription & Dosage Information - MPR
RELiZORB prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and RELiZORBside effects.
HOW RELiZORB® (iMMOBILIZED LIPASE) CARTRIDGE WORKS
RELiZORB is designed for use with enteral feeding pump systems with low flow/no flow alarms and enteral syringes for manual bolus by syringe (push or gravity). A detailed listing of …
Products | Alcresta Therapeutics
Our lead device is RELiZORB ® —a cartridge that reliably and efficiently helps deliver nutritional and caloric benefit from existing enteral feeding formulas. RELiZORB can be used in hospital …
Alcresta Therapeutics | Enzyme products designed for enteral …
RELiZORB is the only FDA-cleared product indicated to break down fats in enteral formula and is intended to address fat malabsorption associated with tube feeding across a variety of disease …